US Stock MarketDetailed Quotes

Avanos Medical (AVNS)

Watchlist
  • 24.660
  • -0.050-0.20%
Close Apr 24 16:00 ET
  • 24.660
  • 0.0000.00%
Post 17:34 ET
1.15BMarket Cap-15.71P/E (TTM)

Avanos Medical (AVNS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
1.95%701.2M
0.72%180.9M
4.34%177.8M
1.92%175M
0.84%167.5M
2.15%687.8M
3.64%179.6M
-0.53%170.4M
1.36%171.7M
4.27%166.1M
Operating revenue
1.95%701.2M
0.72%180.9M
4.34%177.8M
1.92%175M
0.84%167.5M
2.15%687.8M
3.64%179.6M
-0.53%170.4M
1.36%171.7M
4.27%166.1M
Cost of revenue
13.31%347.3M
16.30%94.9M
18.45%91.8M
8.94%82.9M
8.98%77.7M
4.39%306.5M
4.21%81.6M
2.24%77.5M
6.28%76.1M
5.01%71.3M
Gross profit
-7.19%353.9M
-12.24%86M
-7.43%86M
-3.66%92.1M
-5.27%89.8M
0.42%381.3M
3.16%98M
-2.72%92.9M
-2.25%95.6M
3.72%94.8M
Operating expense
-0.67%338.5M
4.64%83.5M
6.18%85.9M
0.34%89.6M
-12.44%79.5M
-9.24%340.8M
-4.77%79.8M
-14.21%80.9M
-10.61%89.3M
-6.87%90.8M
Selling and administrative expenses
-0.91%315.6M
-1.13%78.8M
4.44%77.6M
3.21%83.5M
-9.45%75.7M
-4.93%318.5M
6.98%79.7M
-5.59%74.3M
-13.01%80.9M
-5.86%83.6M
Research and development costs
-11.07%23.3M
7.02%6.1M
-16.67%6M
-7.94%5.8M
-22.86%5.4M
-3.68%26.2M
-16.18%5.7M
18.03%7.2M
-7.35%6.3M
-6.67%7M
Other operating expenses
89.74%-400K
75.00%-1.4M
483.33%2.3M
-85.71%300K
-900.00%-1.6M
-129.32%-3.9M
-324.00%-5.6M
-106.32%-600K
2,000.00%2.1M
-83.33%200K
Operating profit
-61.98%15.4M
-86.26%2.5M
-99.17%100K
-60.32%2.5M
157.50%10.3M
864.29%40.5M
62.50%18.2M
900.00%12M
400.00%6.3M
165.57%4M
Net non-operating interest income expense
35.21%-4.6M
35.00%-1.3M
48.00%-1.3M
-1,300.00%-1.4M
76.00%-600K
41.32%-7.1M
13.04%-2M
34.21%-2.5M
96.67%-100K
16.67%-2.5M
Non-operating interest income
-37.25%3.2M
-25.00%600K
-28.57%500K
-80.00%600K
150.00%1.5M
75.86%5.1M
-20.00%800K
-22.22%700K
500.00%3M
20.00%600K
Non-operating interest expense
-36.07%7.8M
-32.14%1.9M
-43.75%1.8M
-35.48%2M
-32.26%2.1M
-18.67%12.2M
-15.15%2.8M
-31.91%3.2M
-11.43%3.1M
-11.43%3.1M
Other net income (expense)
82.37%-77M
0
-77M
-436.7M
Special income (charges)
82.37%-77M
--0
--0
---77M
----
---436.7M
---436.7M
--0
--0
----
-Less:Impairment of capital assets
-82.37%77M
--0
--0
--77M
----
--436.7M
--436.7M
--0
--0
----
Income before tax
83.59%-66.2M
100.29%1.2M
-112.63%-1.2M
-1,324.19%-75.9M
546.67%9.7M
-5,005.06%-403.3M
-4,824.72%-420.5M
465.38%9.5M
221.57%6.2M
116.48%1.5M
Income tax
139.41%6.7M
110.64%2.5M
-94.44%200K
-52.63%900K
210.00%3.1M
-950.00%-17M
-1,019.05%-23.5M
-41.94%3.6M
337.50%1.9M
176.92%1M
Net income
81.41%-72.9M
99.67%-1.3M
-132.56%-1.4M
-4,366.67%-76.8M
833.33%6.6M
-534.47%-392.1M
-3,883.81%-397.3M
216.22%4.3M
102.64%1.8M
-80.00%-900K
Net income continuous Operations
81.13%-72.9M
99.67%-1.3M
-123.73%-1.4M
-1,886.05%-76.8M
1,220.00%6.6M
-3,802.02%-386.3M
-3,709.09%-397M
167.05%5.9M
200.00%4.3M
106.41%500K
Net income discontinuous operations
--0
--0
--0
--0
--0
88.82%-5.8M
40.00%-300K
-131.37%-1.6M
96.08%-2.5M
-119.18%-1.4M
Minority interest income
Net income attributable to the parent company
81.41%-72.9M
99.67%-1.3M
-132.56%-1.4M
-4,366.67%-76.8M
833.33%6.6M
-534.47%-392.1M
-3,883.81%-397.3M
216.22%4.3M
102.64%1.8M
-80.00%-900K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
81.41%-72.9M
99.67%-1.3M
-132.56%-1.4M
-4,366.67%-76.8M
833.33%6.6M
-534.47%-392.1M
-3,883.81%-397.3M
216.22%4.3M
102.64%1.8M
-80.00%-900K
Basic earnings per share
81.59%-1.57
99.65%-0.03
-133.33%-0.03
-4,250.00%-1.66
800.00%0.14
-546.21%-8.53
-3,856.52%-8.64
212.50%0.09
102.74%0.04
-100.00%-0.02
Diluted earnings per share
81.59%-1.57
99.65%-0.03
-133.33%-0.03
-4,250.00%-1.66
800.00%0.14
-546.21%-8.53
-3,856.52%-8.64
212.50%0.09
102.74%0.04
-100.00%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 1.95%701.2M0.72%180.9M4.34%177.8M1.92%175M0.84%167.5M2.15%687.8M3.64%179.6M-0.53%170.4M1.36%171.7M4.27%166.1M
Operating revenue 1.95%701.2M0.72%180.9M4.34%177.8M1.92%175M0.84%167.5M2.15%687.8M3.64%179.6M-0.53%170.4M1.36%171.7M4.27%166.1M
Cost of revenue 13.31%347.3M16.30%94.9M18.45%91.8M8.94%82.9M8.98%77.7M4.39%306.5M4.21%81.6M2.24%77.5M6.28%76.1M5.01%71.3M
Gross profit -7.19%353.9M-12.24%86M-7.43%86M-3.66%92.1M-5.27%89.8M0.42%381.3M3.16%98M-2.72%92.9M-2.25%95.6M3.72%94.8M
Operating expense -0.67%338.5M4.64%83.5M6.18%85.9M0.34%89.6M-12.44%79.5M-9.24%340.8M-4.77%79.8M-14.21%80.9M-10.61%89.3M-6.87%90.8M
Selling and administrative expenses -0.91%315.6M-1.13%78.8M4.44%77.6M3.21%83.5M-9.45%75.7M-4.93%318.5M6.98%79.7M-5.59%74.3M-13.01%80.9M-5.86%83.6M
Research and development costs -11.07%23.3M7.02%6.1M-16.67%6M-7.94%5.8M-22.86%5.4M-3.68%26.2M-16.18%5.7M18.03%7.2M-7.35%6.3M-6.67%7M
Other operating expenses 89.74%-400K75.00%-1.4M483.33%2.3M-85.71%300K-900.00%-1.6M-129.32%-3.9M-324.00%-5.6M-106.32%-600K2,000.00%2.1M-83.33%200K
Operating profit -61.98%15.4M-86.26%2.5M-99.17%100K-60.32%2.5M157.50%10.3M864.29%40.5M62.50%18.2M900.00%12M400.00%6.3M165.57%4M
Net non-operating interest income expense 35.21%-4.6M35.00%-1.3M48.00%-1.3M-1,300.00%-1.4M76.00%-600K41.32%-7.1M13.04%-2M34.21%-2.5M96.67%-100K16.67%-2.5M
Non-operating interest income -37.25%3.2M-25.00%600K-28.57%500K-80.00%600K150.00%1.5M75.86%5.1M-20.00%800K-22.22%700K500.00%3M20.00%600K
Non-operating interest expense -36.07%7.8M-32.14%1.9M-43.75%1.8M-35.48%2M-32.26%2.1M-18.67%12.2M-15.15%2.8M-31.91%3.2M-11.43%3.1M-11.43%3.1M
Other net income (expense) 82.37%-77M0-77M-436.7M
Special income (charges) 82.37%-77M--0--0---77M-------436.7M---436.7M--0--0----
-Less:Impairment of capital assets -82.37%77M--0--0--77M------436.7M--436.7M--0--0----
Income before tax 83.59%-66.2M100.29%1.2M-112.63%-1.2M-1,324.19%-75.9M546.67%9.7M-5,005.06%-403.3M-4,824.72%-420.5M465.38%9.5M221.57%6.2M116.48%1.5M
Income tax 139.41%6.7M110.64%2.5M-94.44%200K-52.63%900K210.00%3.1M-950.00%-17M-1,019.05%-23.5M-41.94%3.6M337.50%1.9M176.92%1M
Net income 81.41%-72.9M99.67%-1.3M-132.56%-1.4M-4,366.67%-76.8M833.33%6.6M-534.47%-392.1M-3,883.81%-397.3M216.22%4.3M102.64%1.8M-80.00%-900K
Net income continuous Operations 81.13%-72.9M99.67%-1.3M-123.73%-1.4M-1,886.05%-76.8M1,220.00%6.6M-3,802.02%-386.3M-3,709.09%-397M167.05%5.9M200.00%4.3M106.41%500K
Net income discontinuous operations --0--0--0--0--088.82%-5.8M40.00%-300K-131.37%-1.6M96.08%-2.5M-119.18%-1.4M
Minority interest income
Net income attributable to the parent company 81.41%-72.9M99.67%-1.3M-132.56%-1.4M-4,366.67%-76.8M833.33%6.6M-534.47%-392.1M-3,883.81%-397.3M216.22%4.3M102.64%1.8M-80.00%-900K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 81.41%-72.9M99.67%-1.3M-132.56%-1.4M-4,366.67%-76.8M833.33%6.6M-534.47%-392.1M-3,883.81%-397.3M216.22%4.3M102.64%1.8M-80.00%-900K
Basic earnings per share 81.59%-1.5799.65%-0.03-133.33%-0.03-4,250.00%-1.66800.00%0.14-546.21%-8.53-3,856.52%-8.64212.50%0.09102.74%0.04-100.00%-0.02
Diluted earnings per share 81.59%-1.5799.65%-0.03-133.33%-0.03-4,250.00%-1.66800.00%0.14-546.21%-8.53-3,856.52%-8.64212.50%0.09102.74%0.04-100.00%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More